Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis.
Kozic
Heidi
H
Riggs
Karen
K
Ringpfeil
Franziska
F
Lee
Jason B
JB
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003453:Cryptococcosis / Q000209:etiology* / Q000473:pathology; D003455:Cryptococcus neoformans; D003872:Dermatitis / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab